Roivant Sciences Ltd. is a pharmaceutical company that in-licenses late-stage drug candidates and develops them through subsidiaries. Roivant and its subsidiaries have operations in San Francisco, San Diego, Irvine and Brisbane, California; Cambridge, Massachusetts; Durham, North Carolina; New York; Beijing and Shanghai, China, Basel, Switzerland and Vancouver, Canada.The company was founded in 2014 by Vivek Ramaswamy. The company's leadership includes: Mayukh Sukhatme, Matthew Gline, Myrtle Potter, Frank Torti, Adele Gulfo, Sam Azoulay, Ben Zimmer and Allen Waxman.In June 2018, Roivant laid off 67 employees and reassigned 130 to subsidiaries.